top of page
3D Scans

Testicular cancer stages

Testicular cancer stages in-depth 

Testicular cancer staging in-depth and the TNM system

 The TNM system is used to stage the disease based on the specific characteristics of testicular tumours. Here's how the TNM system applies to testicular cancer staging:

  1. Tumor (T):

    • TX: The primary tumour cannot be assessed.

    • T0: No evidence of a primary tumour in the testicle.

    • Tis: Carcinoma in situ (non-invasive cancer) confined to the testicular tubules.

    • T1: Tumor limited to the testicle and epididymis, without invasion of blood vessels or lymphatic vessels.

    • T2: Tumor invades blood vessels or lymphatic vessels within the testicle.

    • T3: Tumor extends beyond the testicle or invades the spermatic cord.

    • T4: Tumor invades the scrotum or skin of the testicle.

  2. Node (N):

    • NX: Regional lymph nodes cannot be assessed.

    • N0: No involvement of regional lymph nodes.

    • N1: Cancer has spread to lymph nodes in the abdomen, pelvis, or groin, measuring 2 centimeters (cm) or smaller.

    • N2: Cancer has spread to lymph nodes in the abdomen, pelvis, or groin, measuring more than 2 cm but not exceeding 5 cm.

    • N3: Cancer has spread to lymph nodes in the abdomen, pelvis, or groin, measuring more than 5 cm.

  3. Metastasis (M):

    • MX: Distant metastasis cannot be assessed.

    • M0: No evidence of distant metastasis.

    • M1: Distant metastasis is present, indicating spread to organs beyond the regional lymph nodes, such as the lungs, liver, bones, or brain.

Combining the T, N, and M categories leads to the overall staging of testicular cancer:

  • Stage 0 (Tis, N0, M0): Carcinoma in situ, non-invasive cancer within the testicular tubules.

  • Stage I (T1-T2, N0-N1, M0): Cancer confined to the testicle or with limited spread to nearby lymph nodes.

  • Stage II (T1-T2, N2-N3, M0): Cancer spread to lymph nodes further away from the testicle.

  • Stage III (T3-T4, N0-N3, M1): Advanced cancer with spread beyond the lymph nodes to distant organs.

The specific staging and treatment approach for testicular cancer can vary based on the tumor type (seminoma or non-seminoma) and additional factors such as tumor marker levels. Proper staging helps guide treatment decisions and provides valuable information regarding the prognosis and expected outcomes for individuals diagnosed with testicular cancer.

Understanding the Staging of Testicular Cancer: A Comprehensive Overview

Testicular cancer is a relatively rare but highly treatable form of cancer that develops in the testicles, the male reproductive glands responsible for producing sperm and testosterone. Like other forms of cancer, testicular cancer is staged to determine the extent and spread of the disease, aiding in treatment planning and prognosis evaluation. This article aims to provide a comprehensive overview of the staging process for testicular cancer, outlining the different stages and their implications.

Stages of Testicular Cancer:

Testicular cancer staging is primarily based on the American Joint Committee on Cancer (AJCC) TNM system, which assesses the tumor size


(T), lymph node involvement

(N), and distant metastasis (M).

The stages range from stage 0 (carcinoma in situ) to stage IV (advanced metastatic disease).

  1. Stage 0 (Carcinoma in Situ): Stage 0, also known as carcinoma in situ or non-invasive testicular germ cell tumor, refers to the presence of abnormal cells within the testicles that have not spread beyond the confines of the seminiferous tubules. At this stage, the cancer is localized and hasn't invaded deeper tissue or spread to nearby lymph nodes. 

  2. Stage I: In stage I testicular cancer, the tumor is still confined to the testicle but has invaded the tissue layers beyond the tubules. Stage I is further divided into two subcategories:

    a) Stage IA: The tumor is limited to the testicle and epididymis (a coiled tube behind the testicle) without any lymph node involvement.

    b) Stage IB: The tumor has spread to blood or lymph vessels located in the testicle, or the tumor has reached the outermost layer of the testicle and may have invaded the epididymis. There is no lymph node involvement.

  3. Stage II: Stage II testicular cancer denotes the presence of cancer that has spread to the retroperitoneal lymph nodes, which are situated at the back of the abdominal cavity. Stage II is further divided into two subcategories:

    a) Stage IIA: The cancer has spread to retroperitoneal lymph nodes measuring 2 centimeters (cm) or smaller.

    b) Stage IIB: The cancer has spread to retroperitoneal lymph nodes larger than 2 cm but not exceeding 5 cm.

  4. Stage III: Stage III testicular cancer signifies the presence of cancer that has spread beyond the retroperitoneal lymph nodes to distant organs or lymph nodes. Stage III is further divided into three subcategories:

    a) Stage IIIA: Cancer has spread to distant lymph nodes but not to other organs.

    b) Stage IIIB: Cancer has metastasized to distant organs, such as the lungs, liver, bones, or brain, without involving non-regional lymph nodes.

    c) Stage IIIC: Cancer has spread to both distant organs and non-regional lymph nodes.

  5. Stage IV: Stage IV testicular cancer represents the most advanced stage, characterized by the spread of cancer to distant organs and non-regional lymph nodes. This stage indicates a higher likelihood of metastasis, potentially involving multiple organs.


Treatment and Prognosis:

The staging of testicular cancer plays a vital role in determining the appropriate treatment approach. Common treatment options include surgery, chemotherapy, and radiation therapy, often used in combination.

The prognosis for testicular cancer is generally favorable, with a high cure rate. The overall survival rate depends on several factors, including the cancer stage, tumor type, and individual patient characteristics. Earlier-stage cancers (Stage I and some Stage II) generally have a more favorable prognosis compared to advanced-stage cancers (Stage III and IV).


Staging is a crucial process in the management of testicular cancer, providing valuable information about the extent of the disease and guiding treatment decisions. Understanding the various stages of testicular cancer helps healthcare professionals devise personalized treatment plans and predict the potential outcomes for patients. With advancements in medical science and early detection, testicular cancer continues to have high survival rates, emphasizing the importance of regular self-examinations and prompt medical attention for any concerning symptoms.

bottom of page